Literature DB >> 11044493

Regulation of fatty acid transport protein and mitochondrial and peroxisomal beta-oxidation gene expression by fatty acids in developing rats.

F Ouali1, F Djouadi, C Merlet-Bénichou, B Riveau, J Bastin.   

Abstract

Regulation of genes involved in fatty acid (FA) utilization in heart and liver of weanling rats was investigated in response to variations in dietary lipid content and to changes in intracellular FA homeostasis induced by etomoxir, a blocker of FA import into mitochondria. Northern-blot analyses were performed using cDNA probes specific for FA transport protein, a cell membrane FA transporter; long-chain- and medium-chain acyl-CoA dehydrogenases, which catalyze the first step of mitochondrial FA beta-oxidation; and acyl-CoA oxidase, a peroxisomal FA beta-oxidation marker. High-fat feeding from postnatal d 21 to 28 resulted in a coordinate increase (58 to 136%) in mRNA abundance of all genes in heart. In liver, diet-induced changes in mitochondrial and peroxisomal beta-oxidation enzyme mRNAs (from 52 to 79%) occurred with no change in FA transport protein gene expression. In both tissues, the increases in mRNA levels went together with parallel increases in enzyme activity. Changes in FA homeostasis resulting from etomoxir administration led to a marked stimulation (76 to 180%) in cardiac expression of all genes together with parallel increases in enzyme activities. In the liver, in contrast, etomoxir stimulated the expression of acyl-CoA oxidase gene only. Feeding rats a low-fat diet containing 0.5% clofibrate, a ligand of peroxisome proliferator-activated receptor alpha, resulted in similar inductions of beta-oxidation enzyme genes in both tissues, whereas up-regulation of FA transport protein gene was restricted to heart. Altogether, these data suggest that changes in FA homeostasis in immature organs resulting either from high-fat diet or beta-oxidation blockade can efficiently be transduced to the level of gene expression, resulting in tissue-specific adaptations in various FA-using enzymes and proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044493     DOI: 10.1203/00006450-200011000-00023

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

Review 1.  A current review of fatty acid transport proteins (SLC27).

Authors:  Andreas Stahl
Journal:  Pflugers Arch       Date:  2003-07-11       Impact factor: 3.657

2.  Effects of Choline on DNA Methylation and Macronutrient Metabolic Gene Expression in In Vitro Models of Hyperglycemia.

Authors:  Xinyin Jiang; Esther Greenwald; Chauntelle Jack-Roberts
Journal:  Nutr Metab Insights       Date:  2016-04-07

3.  Pharmacologic activation of peroxisome proliferator-activating receptor-α accelerates hepatic fatty acid oxidation in neonatal pigs.

Authors:  Kwanseob Shim; Sheila Jacobi; Jack Odle; Xi Lin
Journal:  Oncotarget       Date:  2018-05-08

4.  Functional Effects of EPS-Producing Bifidobacterium Administration on Energy Metabolic Alterations of Diet-Induced Obese Mice.

Authors:  Nuria Salazar; Audrey M Neyrinck; Laure B Bindels; Céline Druart; Patricia Ruas-Madiedo; Patrice D Cani; Clara G de Los Reyes-Gavilán; Nathalie M Delzenne
Journal:  Front Microbiol       Date:  2019-08-07       Impact factor: 5.640

5.  Analysis of Mitochondrial Proteins in the Surviving Myocardium after Ischemia Identifies Mitochondrial Pyruvate Carrier Expression as Possible Mediator of Tissue Viability.

Authors:  Mariana Fernández-Caggiano; Oleksandra Prysyazhna; Javier Barallobre-Barreiro; Ramón CalviñoSantos; Guillermo Aldama López; Maria Generosa Crespo-Leiro; Philip Eaton; Nieves Doménech
Journal:  Mol Cell Proteomics       Date:  2015-11-18       Impact factor: 5.911

Review 6.  Integrated physiology and systems biology of PPARα.

Authors:  Sander Kersten
Journal:  Mol Metab       Date:  2014-03-06       Impact factor: 7.422

Review 7.  The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism.

Authors:  Sha Li; Yu Xu; Wei Guo; Feiyu Chen; Cheng Zhang; Hor Yue Tan; Ning Wang; Yibin Feng
Journal:  Front Pharmacol       Date:  2020-03-24       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.